IKs channels open slowly because KCNE1 accessory subunits slow the movement of S4 voltage sensors in KCNQ1 pore-forming subunits. 2013

Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
Department of Biochemistry, Brandeis University, Waltham, MA 02454, USA.

Human I(Ks) channels activate slowly with the onset of cardiac action potentials to repolarize the myocardium. I(Ks) channels are composed of KCNQ1 (Q1) pore-forming subunits that carry S4 voltage-sensor segments and KCNE1 (E1) accessory subunits. Together, Q1 and E1 subunits recapitulate the conductive and kinetic properties of I(Ks). How E1 modulates Q1 has been unclear. Investigators have variously posited that E1 slows the movement of S4 segments, slows opening and closing of the conduction pore, or modifies both aspects of electromechanical coupling. Here, we show that Q1 gating current can be resolved in the absence of E1, but not in its presence, consistent with slowed movement of the voltage sensor. E1 was directly demonstrated to slow S4 movement with a fluorescent probe on the Q1 voltage sensor. Direct correlation of the kinetics of S4 motion and ionic current indicated that slowing of sensor movement by E1 was both necessary and sufficient to determine the slow-activation time course of I(Ks).

UI MeSH Term Description Entries
D007758 Ear, Inner The essential part of the hearing organ consists of two labyrinthine compartments: the bony labyrinthine and the membranous labyrinth. The bony labyrinth is a complex of three interconnecting cavities or spaces (COCHLEA; VESTIBULAR LABYRINTH; and SEMICIRCULAR CANALS) in the TEMPORAL BONE. Within the bony labyrinth lies the membranous labyrinth which is a complex of sacs and tubules (COCHLEAR DUCT; SACCULE AND UTRICLE; and SEMICIRCULAR DUCTS) forming a continuous space enclosed by EPITHELIUM and connective tissue. These spaces are filled with LABYRINTHINE FLUIDS of various compositions. Labyrinth,Bony Labyrinth,Ear, Internal,Inner Ear,Membranous Labyrinth,Bony Labyrinths,Ears, Inner,Ears, Internal,Inner Ears,Internal Ear,Internal Ears,Labyrinth, Bony,Labyrinth, Membranous,Labyrinths,Labyrinths, Bony,Labyrinths, Membranous,Membranous Labyrinths
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D004553 Electric Conductivity The ability of a substrate to allow the passage of ELECTRONS. Electrical Conductivity,Conductivity, Electric,Conductivity, Electrical
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015640 Ion Channel Gating The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability. Gating, Ion Channel,Gatings, Ion Channel,Ion Channel Gatings
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses
D051657 KCNQ1 Potassium Channel A voltage-gated potassium channel that is expressed primarily in the HEART. KCNQ1 Protein,KVLQT1 Protein,Kv7.1 Potassium Channel,Voltage-Gated K+ Channel KCNQ1,Potassium Channel, KCNQ1,Potassium Channel, Kv7.1,Voltage Gated K+ Channel KCNQ1

Related Publications

Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
April 2014, Nature communications,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
December 2020, International journal of molecular sciences,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
September 2007, The Journal of general physiology,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
April 2014, Proceedings of the National Academy of Sciences of the United States of America,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
December 2008, Circulation research,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
January 2011, The Journal of biological chemistry,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
June 2014, Nature communications,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
January 2012, Frontiers in pharmacology,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
December 2015, Journal of molecular and cellular cardiology,
Katarina J Ruscic, and Francesco Miceli, and Carlos A Villalba-Galea, and Hui Dai, and Yukiko Mishina, and Francisco Bezanilla, and Steve A N Goldstein
May 2022, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!